Blue Trust Inc’s DiaMedica Therapeutics DMAC Stock Holding History

Blue Trust Inc’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$572K	Hold	69,122	–	–	0.01%	439
2026 Q2	$487K	Hold	69,122	–	–	0.01%	495
2026 Q1	$468K	Hold	69,122	–	–	0.01%	500
2025 Q4	$550K	Hold	69,122	–	–	0.01%	453
2025 Q3	$475K	Hold	69,122	–	–	0.01%	510
2025 Q2	$270K	Hold	69,122	–	–	﹤0.01%	660
2025 Q1	$262K	Hold	69,122	–	–	﹤0.01%	619
2024 Q4	$375K	Buy	69,122 +24,875	+56%	+$117K	﹤0.01%	455
2024 Q3	$131K	Buy	+44,247	New	+$163K	﹤0.01%	1078

Other funds holding DMAC

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Blue Trust Inc's DMAC Position: Q3 2026 in Review

Blue Trust Inc held its DiaMedica Therapeutics (DMAC) position steady in Q3 2026 at 69,122 shares worth $572K. The position accounts for 0.01% of the portfolio, ranked #439.

Blue Trust Inc first reported a position in DMAC in Q3 2024 and has held it in 9 quarters since. 6 funds tracked by Wall St. Rank hold DMAC as of Q3 2026.

Blue Trust Inc held 69,122 shares of DiaMedica Therapeutics worth $572K as of Q3 2026.
Blue Trust Inc left its DiaMedica Therapeutics share count unchanged in Q3 2026.
DiaMedica Therapeutics made up 0.01% of Blue Trust Inc's portfolio in Q3 2026, its #439 holding.
Blue Trust Inc first reported a position in DiaMedica Therapeutics in Q3 2024 and has held it in 9 quarters since.
6 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.